Correlation Between Pasithea Therapeutics and 10X Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and 10X Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and 10X Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and 10X Genomics, you can compare the effects of market volatilities on Pasithea Therapeutics and 10X Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of 10X Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and 10X Genomics.

Diversification Opportunities for Pasithea Therapeutics and 10X Genomics

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pasithea and 10X is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and 10X Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X Genomics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with 10X Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X Genomics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and 10X Genomics go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and 10X Genomics

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 1.38 times more return on investment than 10X Genomics. However, Pasithea Therapeutics is 1.38 times more volatile than 10X Genomics. It trades about -0.04 of its potential returns per unit of risk. 10X Genomics is currently generating about -0.06 per unit of risk. If you would invest  2.10  in Pasithea Therapeutics Corp on August 31, 2024 and sell it today you would lose (0.07) from holding Pasithea Therapeutics Corp or give up 3.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy50.0%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  10X Genomics

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
10X Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 10X Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pasithea Therapeutics and 10X Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and 10X Genomics

The main advantage of trading using opposite Pasithea Therapeutics and 10X Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, 10X Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X Genomics will offset losses from the drop in 10X Genomics' long position.
The idea behind Pasithea Therapeutics Corp and 10X Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments